{"id":"d150b130-4acf-46a5-b29c-b7197a55abe9","kind":"news","code":"d150b130-4acf-46a5-b29c-b7197a55abe9","name":"Yiyuan Biotechnology completes equity financing","nameBasis":"translated-title","summary":"On 2026-08-31, according to Xiniu Data, Yiyuan Biotechnology completed equity financing for an undisclosed amount. Investors were Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership). The company is a developer of embodied intelligent medical devices.","description":"","country":null,"category":null,"originalName":"翌远生物完成股权投资融资","eventDate":"2026-08-31T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T16:32:29.704Z","englishUpdatedAt":"2026-10-20T18:31:05.514Z","reviewedAt":"2026-10-20T18:31:05.514Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"00151465f94b2cf7481d271666697a313b152d6ed50ed17d63e9918a2304f550","companyId":"577a8b45-06e2-45d0-afb6-b8e7d9fd6dda","foundedYear":null,"logoUrl":null,"originalText":"2026年8月31日，据烯牛数据报道，翌远生物完成股权投资融资，金额未披露。投资方为昆山天使二期投资基金合伙企业（有限合伙）。该公司为具身智能医疗器械研发商。","sources":[],"related":[{"id":"212c2c33-bde9-4f07-ab7d-ece6d2b80cd8","kind":"institutions","code":"UB-I7209","name":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","description":"Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership), an angel investment firm focused on early-stage projects.","country":null,"category":null,"originalName":"昆山天使二期投资基金合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.306Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"8d558f103d810a8ff956694a34889475e888533da5152c1837eab327f18a4cb8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/kunshantianshi-phase-two-investment-fund-partnership-limited-partnership"},{"id":"577a8b45-06e2-45d0-afb6-b8e7d9fd6dda","kind":"companies","code":"UB-C9904","name":"Yiyuan Biotechnology","nameBasis":"transliterated","summary":"Developer of embodied intelligent medical devices.","description":"Developer of embodied intelligent medical devices.","country":"China","category":null,"originalName":"翌远生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:24:40.643Z","reviewedAt":"2026-10-20T18:24:40.643Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"9be6fad7c8dfac3ce1a104456b2aa8420cb96089a2edb046f077a4af899c29aa","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C9904"}],"path":"/news/d150b130-4acf-46a5-b29c-b7197a55abe9","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Yiyuan Biotechnology","path":"/companies/UB-C9904"}},"canonical":"https://uniquebase.ai/news/d150b130-4acf-46a5-b29c-b7197a55abe9"}